MAIA Biotechnology, Inc. (($MAIA)) announced an update on their ongoing clinical study. MAIA Biotechnology, Inc. has announced a new Phase III ...
Vir Biotechnology, Inc. (($VIR)) announced an update on their ongoing clinical study. Vir Biotechnology, Inc. is conducting a Phase 1 study titled ...
A new study published in Nature Biotechnology shows that stem cell differentiation is linked to cellular structures called ...
UNITY Biotechnology, Inc. reported its financial results for the first quarter of 2025, highlighting the 24-week and partial 36-week topline data from its Phase 2b ASPIRE study in diabetic macular ...
PDS Biotechnology is hosting a virtual key opinion leader event featuring notable experts in the field, which could enhance the company’s credibility and visibility in the oncological community. The ...
Vir's Phase 2 trial saw 39% and 46% HBsAg loss in doublet and triplet regimens for patients with low baseline HBsAg. 100% of participants in the triplet regimen with HBsAg loss achieved anti-HBs ...
ATHENS, Ga. & SAN JOSE, Calif.--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the ...
On Tuesday, Sana Biotechnology Inc (NASDAQ:SANA) released the initial results from a first-in-human study transplanting UP421, an allogeneic primary islet cell therapy engineered with Sana’s ...
Investors looking for stocks that can produce eye-popping gains in a short time frame often turn toward biotechnology stocks.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback